Skip to main content

Table 1 Characteristics of MMT users

From: Effects of treatment status and life quality on anxiety in MMT patients

 

MMT users (N=177)

Gender (males/females)

155(87.6%)/22(12.4%)

Age

51.8±5.7

Years of education

 ≤9

131(74.0%)

 10–12

44(24.9%)

 ≥13

2(1.1%)

Marital status (single/married)

98(55.4%)/79(44.6%)

Living situation (alone/with partners)

57(32.2%)/120(67.8%)

Drinking status (yes/no)

58(32.8%)/119(67.2%)

Smoking status (yes/no)

174(98.3%)/3(1.7%)

Cumulative duration of heroin use (month)

261.4±82.6

Cumulative duration of MMT (month)

100.9±60.7

Current methadone therapeutic dose (mg)

37.3±22.1

MMT Interruption (yes/no)

72(40.7%)/105(59.3%)

BAI score

7.1±8.2

QOL-DA total score

163.5±21.4

 Physiology Score

33.3±6.5

 Psychology Score

39.6±6.8

 Society Score

39.2±6.9

 Symptoms Score

48.3±7.2

  1. Data are the amount of cases (percentage). Data about age, cumulative duration of heroin use, cumulative duration of MMT, current methadone dose and QOL-DA score are the mean±standard deviation